Inquest into the Death of Mark Leslie SACH

27y · Male·combined drug toxicity (U-47700 and etizolam)

Mark Sach, aged 27, died from combined drug toxicity involving U-47700 (a synthetic opioid 7.5 times more potent than morphine) and etizolam (a benzodiazepine 10 times more potent than diazepam), obtained via internet purchase. He had chronic spinal pain following a 2012 motor vehicle accident and was managed by pain specialists and his GP with medications including pregabalin, tapentadol, clonazepam, and codeine. Dissatisfied with prescribed treatment and concerned about functional impairment, Mr Sach self-medicated with unlicensed substances without disclosing this to medical practitioners. A psychologist had warned him of the dangers in October 2015, but this information was not followed up before his death. The case highlights challenges in chronic pain management, including long wait times, appointment spacing of 6-9 months, lack of care continuity, and patient dissatisfaction with conservative opioid prescribing policies. Clinicians should maintain a high index of suspicion for undisclosed self-medication in frustrated chronic pain patients, improve communication about evidence-based opioid restrictions, and ensure timely follow-up of disclosures about non-prescribed substance use.